Primary chemotherapy versus primary surgery for ovarian cancer - Authors' reply. (2015)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(15)01052-1
PubMed Identifier: 26638963
Publication URI: http://europepmc.org/abstract/MED/26638963
Type: Journal Article/Review
Volume: 386
Parent Publication: Lancet (London, England)
Issue: 10009
ISSN: 0140-6736